Review and development of referral criteria used to identify patients with diabetes who would benefit from attending a pharmacist-led cardiovascular out-patient clinic
Permanent lenke
https://hdl.handle.net/10037/4329Dato
2012-05Type
Master thesisMastergradsoppgave
Forfatter
Westerhus, Ingvild RisanSammendrag
Abstract
Development and validation of new referral criteria: a triangulation study at the Pharmacist-led Diabetes Cardiovascular risk Reduction Clinic, Edinburgh.
The Pharmacist-led Diabetes Cardiovascular risk Reduction (DCVR) clinic has been running at the Western General Hospital (WGH), Edinburgh, for 8 years. It was decided to review the referral process of patients and the referral criteria.
Semi-structured interviews were performed with nine clinicians at the diabetes clinic, WGH. The interviews were transcribed and analysed with thematic codes. New referral criteria were developed and applied to a cross-sectional survey of 1000 patients selected randomly from a total of 2911 patients registered at the diabetes clinic at the 19th of March 2012. Data was recorded on a database for 944 patients from the main list of 1000 patients identified from the Scottish Care Information – Diabetes Collaboration (SCI-DC).
Eight clinicians were referring patients to the clinic and one clinician was not aware of the clinic and only four clinicians were aware of the referral form. The interviews showed that clinicians’ main reason for referring patients was blood pressure control in complicated patients. The five combinations with most referred patients identified had two criteria in common: systolic BP >130 mmHg and microalbumin >2.5 mg/mmol.
To provide a consistent service for patients there is a requirement for continuity in referral of patients to the pharmacist-led DCVR clinic. Our findings suggest there is a need to raise awareness of the clinic among physicians and to improve communication between physicians and pharmacist in terms of patient outcomes.
Forlag
Universitetet i TromsøUniversity of Tromsø
Metadata
Vis full innførselSamlinger
Copyright 2012 The Author(s)
Følgende lisensfil er knyttet til denne innførselen:
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0)
Relaterte innførsler
Viser innførsler relatert til tittel, forfatter og emneord.
-
Influence of environmental tonicity changes on lipophilic drug release from liposomes
Nikolaisen, Trygg Einar (Mastergradsoppgave; Master thesis, 2018-05-15)Introduction: Liposomes as drug delivery systems has been widely studied as a way to solubilize poorly soluble drugs, reduce side effects of chemotherapeutics and increase circulation time in vivo. Since the first descriptions of liposomes over 60 years ago, they have shown tendencies to shrink and swell when the external environment of the liposomes is altered. This phenomenon has been studied in ... -
The Temporomandibular Joint in Juvenile Idiopathic Arthritis, focusing on Quality of Life, Oral Microbiome and Intervention
Frid, Paula (Doctoral thesis; Doktorgradsavhandling, 2020-10-02)The temporomandibular joint (TMJ) is commonly involved in juvenile idiopathic arthritis (JIA), and may lead to impaired mouth opening, pain and facial growth disturbances. Asymptomatic TMJ arthritis may be diagnosed late in the disease course, thus management is challenging. The overall objectives of this thesis were to provide new knowledge on quality of life (QoL), the oral microbiome and interventions ... -
Prognostic Impacts of Angiopoietins in NSCLC Tumor Cells and Stroma : VEGF-A Impact Is Strongly Associated with Ang-2
Andersen, Sigve; Dønnem, Tom; Al-Shibli, Khalid Ibrahim; Al-Saad, Samer; Stenvold, Helge; Busund, Lill-Tove; Bremnes, Roy M. (Journal article; Tidsskriftartikkel; Peer reviewed, 2011)Angiopoietins and their receptor Tie-2 are, in concert with VEGF-A, key mediators in angiogenesis. This study evaluates the prognostic impact of all known human angiopoietins (Ang-1, Ang-2 and Ang-4) and their receptor Tie-2, as well as their relation to the prognostic expression of VEGF-A. 335 unselected stage I-IIIA NSCLC-patients were included and tissue samples of respective tumor cells and ...